
The global Genome Editing Techniques market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Genome Editing Techniques is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Genome Editing Techniques is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Genome Editing Techniques in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Genome Editing Techniques include Synthego, Thermo Fisher Scientific, Inc., GenScript, Addgene, Merck, Integrated DNA Technologies, Inc., Transposagen Biopharmaceuticals, Inc., OriGene Technologies, Inc. and New England Biolabs, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Genome Editing Techniques, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genome Editing Techniques.
Report Scope
The Genome Editing Techniques market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Genome Editing Techniques market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genome Editing Techniques companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Synthego
Thermo Fisher Scientific, Inc.
GenScript
Addgene
Merck
Integrated DNA Technologies, Inc.
Transposagen Biopharmaceuticals, Inc.
OriGene Technologies, Inc.
New England Biolabs
Horizon Discovery Group Co.
Cellecta, Inc.
Agilent Technologies
Applied StemCell, Inc.
Segment by Type
Zinc Finger Nucleases (ZFNs)
Transcription Activator-like Effector Nucleases (TALENs)
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
Others
Segment by Application
Hospital
Laborary
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genome Editing Techniques companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genome Editing Techniques Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Zinc Finger Nucleases (ZFNs)
1.2.3 Transcription Activator-like Effector Nucleases (TALENs)
1.2.4 Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
1.2.5 Others
1.3 Market by Application
1.3.1 Global Genome Editing Techniques Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Laborary
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genome Editing Techniques Market Perspective (2019-2030)
2.2 Genome Editing Techniques Growth Trends by Region
2.2.1 Global Genome Editing Techniques Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Genome Editing Techniques Historic Market Size by Region (2019-2024)
2.2.3 Genome Editing Techniques Forecasted Market Size by Region (2025-2030)
2.3 Genome Editing Techniques Market Dynamics
2.3.1 Genome Editing Techniques Industry Trends
2.3.2 Genome Editing Techniques Market Drivers
2.3.3 Genome Editing Techniques Market Challenges
2.3.4 Genome Editing Techniques Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genome Editing Techniques Players by Revenue
3.1.1 Global Top Genome Editing Techniques Players by Revenue (2019-2024)
3.1.2 Global Genome Editing Techniques Revenue Market Share by Players (2019-2024)
3.2 Global Genome Editing Techniques Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Genome Editing Techniques Revenue
3.4 Global Genome Editing Techniques Market Concentration Ratio
3.4.1 Global Genome Editing Techniques Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genome Editing Techniques Revenue in 2023
3.5 Genome Editing Techniques Key Players Head office and Area Served
3.6 Key Players Genome Editing Techniques Product Solution and Service
3.7 Date of Enter into Genome Editing Techniques Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Genome Editing Techniques Breakdown Data by Type
4.1 Global Genome Editing Techniques Historic Market Size by Type (2019-2024)
4.2 Global Genome Editing Techniques Forecasted Market Size by Type (2025-2030)
5 Genome Editing Techniques Breakdown Data by Application
5.1 Global Genome Editing Techniques Historic Market Size by Application (2019-2024)
5.2 Global Genome Editing Techniques Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Genome Editing Techniques Market Size (2019-2030)
6.2 North America Genome Editing Techniques Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Genome Editing Techniques Market Size by Country (2019-2024)
6.4 North America Genome Editing Techniques Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Genome Editing Techniques Market Size (2019-2030)
7.2 Europe Genome Editing Techniques Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Genome Editing Techniques Market Size by Country (2019-2024)
7.4 Europe Genome Editing Techniques Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genome Editing Techniques Market Size (2019-2030)
8.2 Asia-Pacific Genome Editing Techniques Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Genome Editing Techniques Market Size by Region (2019-2024)
8.4 Asia-Pacific Genome Editing Techniques Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Genome Editing Techniques Market Size (2019-2030)
9.2 Latin America Genome Editing Techniques Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Genome Editing Techniques Market Size by Country (2019-2024)
9.4 Latin America Genome Editing Techniques Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genome Editing Techniques Market Size (2019-2030)
10.2 Middle East & Africa Genome Editing Techniques Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Genome Editing Techniques Market Size by Country (2019-2024)
10.4 Middle East & Africa Genome Editing Techniques Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Synthego
11.1.1 Synthego Company Detail
11.1.2 Synthego Business Overview
11.1.3 Synthego Genome Editing Techniques Introduction
11.1.4 Synthego Revenue in Genome Editing Techniques Business (2019-2024)
11.1.5 Synthego Recent Development
11.2 Thermo Fisher Scientific, Inc.
11.2.1 Thermo Fisher Scientific, Inc. Company Detail
11.2.2 Thermo Fisher Scientific, Inc. Business Overview
11.2.3 Thermo Fisher Scientific, Inc. Genome Editing Techniques Introduction
11.2.4 Thermo Fisher Scientific, Inc. Revenue in Genome Editing Techniques Business (2019-2024)
11.2.5 Thermo Fisher Scientific, Inc. Recent Development
11.3 GenScript
11.3.1 GenScript Company Detail
11.3.2 GenScript Business Overview
11.3.3 GenScript Genome Editing Techniques Introduction
11.3.4 GenScript Revenue in Genome Editing Techniques Business (2019-2024)
11.3.5 GenScript Recent Development
11.4 Addgene
11.4.1 Addgene Company Detail
11.4.2 Addgene Business Overview
11.4.3 Addgene Genome Editing Techniques Introduction
11.4.4 Addgene Revenue in Genome Editing Techniques Business (2019-2024)
11.4.5 Addgene Recent Development
11.5 Merck
11.5.1 Merck Company Detail
11.5.2 Merck Business Overview
11.5.3 Merck Genome Editing Techniques Introduction
11.5.4 Merck Revenue in Genome Editing Techniques Business (2019-2024)
11.5.5 Merck Recent Development
11.6 Integrated DNA Technologies, Inc.
11.6.1 Integrated DNA Technologies, Inc. Company Detail
11.6.2 Integrated DNA Technologies, Inc. Business Overview
11.6.3 Integrated DNA Technologies, Inc. Genome Editing Techniques Introduction
11.6.4 Integrated DNA Technologies, Inc. Revenue in Genome Editing Techniques Business (2019-2024)
11.6.5 Integrated DNA Technologies, Inc. Recent Development
11.7 Transposagen Biopharmaceuticals, Inc.
11.7.1 Transposagen Biopharmaceuticals, Inc. Company Detail
11.7.2 Transposagen Biopharmaceuticals, Inc. Business Overview
11.7.3 Transposagen Biopharmaceuticals, Inc. Genome Editing Techniques Introduction
11.7.4 Transposagen Biopharmaceuticals, Inc. Revenue in Genome Editing Techniques Business (2019-2024)
11.7.5 Transposagen Biopharmaceuticals, Inc. Recent Development
11.8 OriGene Technologies, Inc.
11.8.1 OriGene Technologies, Inc. Company Detail
11.8.2 OriGene Technologies, Inc. Business Overview
11.8.3 OriGene Technologies, Inc. Genome Editing Techniques Introduction
11.8.4 OriGene Technologies, Inc. Revenue in Genome Editing Techniques Business (2019-2024)
11.8.5 OriGene Technologies, Inc. Recent Development
11.9 New England Biolabs
11.9.1 New England Biolabs Company Detail
11.9.2 New England Biolabs Business Overview
11.9.3 New England Biolabs Genome Editing Techniques Introduction
11.9.4 New England Biolabs Revenue in Genome Editing Techniques Business (2019-2024)
11.9.5 New England Biolabs Recent Development
11.10 Horizon Discovery Group Co.
11.10.1 Horizon Discovery Group Co. Company Detail
11.10.2 Horizon Discovery Group Co. Business Overview
11.10.3 Horizon Discovery Group Co. Genome Editing Techniques Introduction
11.10.4 Horizon Discovery Group Co. Revenue in Genome Editing Techniques Business (2019-2024)
11.10.5 Horizon Discovery Group Co. Recent Development
11.11 Cellecta, Inc.
11.11.1 Cellecta, Inc. Company Detail
11.11.2 Cellecta, Inc. Business Overview
11.11.3 Cellecta, Inc. Genome Editing Techniques Introduction
11.11.4 Cellecta, Inc. Revenue in Genome Editing Techniques Business (2019-2024)
11.11.5 Cellecta, Inc. Recent Development
11.12 Agilent Technologies
11.12.1 Agilent Technologies Company Detail
11.12.2 Agilent Technologies Business Overview
11.12.3 Agilent Technologies Genome Editing Techniques Introduction
11.12.4 Agilent Technologies Revenue in Genome Editing Techniques Business (2019-2024)
11.12.5 Agilent Technologies Recent Development
11.13 Applied StemCell, Inc.
11.13.1 Applied StemCell, Inc. Company Detail
11.13.2 Applied StemCell, Inc. Business Overview
11.13.3 Applied StemCell, Inc. Genome Editing Techniques Introduction
11.13.4 Applied StemCell, Inc. Revenue in Genome Editing Techniques Business (2019-2024)
11.13.5 Applied StemCell, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Synthego
Thermo Fisher Scientific, Inc.
GenScript
Addgene
Merck
Integrated DNA Technologies, Inc.
Transposagen Biopharmaceuticals, Inc.
OriGene Technologies, Inc.
New England Biolabs
Horizon Discovery Group Co.
Cellecta, Inc.
Agilent Technologies
Applied StemCell, Inc.
Ìý
Ìý
*If Applicable.
